Soluble CD30: A Serum Marker for Epstein-Barr Virus-Associated Lymphoproliferative Diseases

Journal of Medical Virology - United States
doi 10.1002/jmv.21953
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2019English

Immune Regulation in Epstein-Barr Virus-Associated Diseases.

Microbiological reviews
1995English

Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Diseases in Chinese Mainland

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2018English

Epstein-Barr Virus-Associated Lymphoproliferative Disease During Imatinib Mesylate Treatment for Chronic Myeloid Leukemia

Haematologica
Hematology
2019English

Epstein-Barr Virus-Associated Γδ T-Cell Lymphoproliferative Disorder Associated With Hypomorphic IL2RG Mutation

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2019English

Epstein–Barr Virus-Associated Lymphoproliferative Disorder After Autologous Bone Marrow Transplantation: Report of Two Cases

Bone Marrow Transplantation
TransplantationHematology
1998English

Characterization of Epstein-Barr Virus Genomes in Transplant Lymphoma/Lymphoproliferative Disease

Pediatric Research
Child HealthPediatricsPerinatology
1987English

Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome

Mediterranean Journal of Hematology and Infectious Diseases
Infectious DiseasesHematology
2012English

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders

Frontiers in Oncology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy